AC

Allegheny Cancer Institute at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Allegheny Cancer Institute brings 1 presentation to AMP 2026 in Seattle. Its program at the meeting covers measurable residual disease detection and monitoring in solid tumors and blood cancers using personalized tumor-informed droplet digital PCR assays in research settings.

OrganizationAMP 2026 Attendance
AC
Allegheny Cancer Institute
Pittsburgh, PA
Med centres
Workshop
Wed, Nov 11
8:00am–8:50am
MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings
Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours.
Workshop hosted by Bio-Rad Laboratories
Tahoma 3, Level 3, Arch at 800 Pike

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Allegheny Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction